Medical Disorders
Basic InformationLookupsLatest News
Drop in Life Expectancy From COVID Much Worse for Black, Hispanic AmericansInnovative Kidney Donor 'Voucher' System Is Saving LivesMental Confusion an Early Warning Sign of Severe COVID-19COVID Caused Biggest Drop in U.S. Life Expectancy Since World War IIClot-Removing Procedure Can Sometimes Backfire for Stroke PatientsFDA to Add Warning to Pfizer, Moderna Vaccines About Rare Heart Issues in YoungAHA News: Silent Heart Attacks All Too Common, and Often OverlookedRash, Itch After COVID Vaccine Rare & Quickly ResolvesStudy Suggests COVID Vaccine Booster Shots Will Be NeededNo Need for Blood Thinners in Patients Sick at Home With COVID-19Heart Issues in Young COVID Vaccine Recipients Rare, Usually Mild and Quickly Resolve: ExpertsMore E-Scooter Rideshares, More InjuriesMore Than Half of People With Asthma Aren't Seeing a SpecialistAutopsy Study Shows How COVID Harms the BrainCOVID Deaths Drop to New Lows in U.S., While Vaccination Rates ClimbNot-So-Happy-Birthdays: Parties Helped Spread COVID, Study FindsAHA News: Should Rare Cases of Heart Inflammation Put Your COVID-19 Vaccine Plans on Hold?Obesity in Teens Raises Adult Diabetes Risk, Even After Weight LossNew Genetic Insights Into Cause of ALSScreen All Kids for Heart Problems, Pediatricians' Group SaysIn 11 States, Seniors' Low Vaccination Rates a 'Powder Keg' for New CasesSickle Cell Plagues Many Black Americans, But There's Hope for Better TreatmentsSurvivors' Plasma Helps Blood Cancer Patients Battle COVID-19Hospitals: One Reason COVID Is More Lethal for Black AmericansMany 'High Priority' Patients Aren't Getting Put on Kidney Transplant ListsU.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVIDRed Cross Warns of Severe Blood ShortageHand Sanitizer Vapors Can Cause Nausea, DizzinessPfizer, Moderna Vaccines Do No Harm to Male Fertility: StudyLess Than 1% of People Who've Had Severe COVID Get Re-InfectedMold a Big Threat to People With COPDWhat Works Best to Ease Migraines?Pandemic Silver Lining: Fewer Dangerous Flare-Ups for COPD PatientsIs Zinc a Friend or Foe to Kidney Stones?Strict Rest Not Recommended After Sports-Linked Concussion, Experts SayEven Good Weather Didn't Lift Lockdown Blues: StudyU.S. ​COVID Death Toll Tops 600,000Third Dose of COVID Vaccine Boosts Protection in Transplant RecipientsCould a Type of Statin Raise Dementia Risks?Many U.S. Seniors May Need Better Knee Arthritis CareAfter COVID, Many Americans Are Struck by New Maladies: StudyCataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study Finds
Questions and AnswersVideosLinksBook Reviews
Related Topics

Men's Health
Women's Health

Common Immune Drug Methotrexate May Hamper Response to COVID-19 Vaccine

HealthDay News
by By Ernie Mundell and Robert Preidt HealthDay Reporters
Updated: May 26th 2021

new article illustration

WEDNESDAY, May 26, 2021 (HealthDay News) -- A widely used medicine for autoimmune diseases may lower people's immune response to the Pfizer mRNA COVID-19 vaccine, a new study suggests.

The drug, called methotrexate, is often given to patients with immune-mediated inflammatory conditions such as rheumatoid arthritis and psoriasis/psoriatic arthritis.

"Our findings suggest that different strategies may need to be explored in patients with immune-mediated inflammatory diseases taking methotrexate to increase the chances of immunization efficacy," said a team led by Dr. Jose Scher of New York University Langone Health in New York City.

In this study, the researchers assessed the immune response to the mRNA Pfizer COVID-19 vaccine in 82 patients with immune-mediated inflammatory diseases. All of the patients were taking either methotrexate or an alternative "immunomodulator" drug (mainly drugs called TNF inhibitors and other biologics). For comparison, Scher's team also looked at vaccine responses in a group of healthy people.

The vaccine triggered "adequate" antibody levels in up to one-third fewer of the patients taking methotrexate, compared with patients on other immunomodulatory drugs or in healthy people, the findings showed.

Adequate antibody levels were seen in more than 90% of the 208 healthy participants and the 37 patients on biologic or non-methotrexate oral treatments, but in only 62% of the 45 patients taking methotrexate, the study found.

The researchers also reported that the vaccine induced activated CD8+ T cell responses in healthy people and patients with immune-mediated inflammatory diseases not on methotrexate, but not in patients on methotrexate. T cells are another part of the body's immune defense system.

The study has been accepted for publication in the journal Annals of the Rheumatic Diseases.

Scher stressed that this was an observational study and can't prove that methotrexate use actually caused the dip in COVID-19 vaccine effectiveness. It also had a small sample size, only assessed one type of mRNA COVID-19 vaccine (the Moderna mRNA vaccine was not tested), and could have included patients with previously asymptomatic COVID-19 infections.

The researchers also noted that patients on methotrexate were generally older than the comparison group (average age 63 versus 49), and that may potentially explain some of the differences in immune response.

Dr. Diane Horowitz is a rheumatologist at Northwell Health in Manhasset, N.Y. She wasn't involved in the new study, but said its findings are no reason for people who take methotrexate to give up on COVID-19 vaccines.

"For the majority of patients on methotrexate or other immunosuppressive medications, the COVID vaccine is strongly recommended," Horowitz said. "These patients should contact their physician to determine the optimal timing of the vaccination."

According to Horowitz, "the American College of Rheumatology recommends that, for patients who are taking methotrexate, that they skip the dose of methotrexate for one week after each mRNA-based COVID vaccination," to help maximize their immune response to the shot.

Scher's team agreed, saying that further study is needed "to determine whether additional doses of vaccine, dose modification of methotrexate, or even temporary discontinuation of this drug can boost immune response."

More information

The U.S. Centers for Disease Control and Prevention has more on mRNA COVID-19 vaccines.

SOURCES: Diane Horowitz, MD, division of rheumatology, Northwell Health, Manhasset, N.Y.; Annals of the Rheumatic Diseases, news release, May 25, 2021


Amazon Smile


Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.


powered by centersite dot net